Precursors of endometrial and ovarian carcinoma
Explore this paper's citation graph
Summary
This review discusses precursor lesions of endometrial and ovarian carcinoma with an emphasis on the unique molecular alterations that have led to the development of binary classification schemes for tumors of both the endometrium and ovary.
- Type
- article
- Published
- 2009-01-01
- Cited by
- 39
- References
- 89
- OpenAlex
- https://openalex.org/W19859732
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:2258424
Keywords
Gens, Political science, Humanities, Philosophy
References
- Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers.
- Mutations of the Ki-ras oncogene in carcinoma of the endometrium.
- K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary.
- Microsatellite instability in endometrial carcinoma.
- Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
- p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis.
- Micropapillary serous carcinoma of the ovary
- Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias.
- K-ras activation in premalignant and malignant epithelial lesions of the human uterus.
- Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
- Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.
- Ovarian Serous Tumors of Low Malignant Potential (Borderline Tumors): Outcome-Based Study of 276 Patients With Long-Term (≥5-Year) Follow-Up
- p53 gene mutations and protein accumulation in human ovarian cancer.
- Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.
- Mutational Analysis of K-ras Segregates Ovarian Serous Carcinomas into Two Types: Invasive MPSC (Low-grade Tumor) and Conventional Serous Carcinoma (High-grade Tumor)
- Current research and treatment for epithelial ovarian cancer. A Position Paper from the Helene Harris Memorial Trust.
- Precursors of Endometrial Clear Cell Carcinoma
- KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
- Endometrial Glandular Dysplasia: A Putative Precursor Lesion of Uterine Papillary Serous Carcinoma. Part II: Molecular Features
- Cystic and Adenofibromatous Clear Cell Carcinomas of the Ovary: Distinctive Tumors That Differ in Their Pathogenesis and Behavior: A Clinicopathologic Analysis of 122 Cases
Cited by
- Improved identification of high risk endometrial carcinoma
- Premalignancies of serous ovarian cancer in Müllerian derived epithelium
- A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleeding.
- CCL22, CD8 und FoxP3 als prognostische Marker beim fortgeschrittenen Ovarialkarzinom-
- Genetic and epigenetic mechanisms of tumor predisposition in hereditary non-polyposis colorectal carcinoma and sporadic cancers
- Combining Endometrium Sampling Device and SurePath Preparation to Screen for Endometrial Carcinoma: A Validation Study
- Expression of αV-Integrins in Uterine Serous Papillary Carcinomas; Implications for Targeted Therapy With Intetumumab (CNTO 95), a Fully Human Antagonist Anti–αV-Integrin Antibody
- Histopathologic assessment of the entire endometrium in asymptomatic women.
- Clinical significance of microRNA expressions in diagnosing uterine cancer and predicting lymph node metastasis
- AGR2 expression in ovarian tumours: a potential biomarker for endometrioid and mucinous differentiation
- Vanishing Endometrial Cancer in Hysterectomy Specimens: A Myth or a Fact
- Villin1, a diagnostic marker for endometrial adenocarcinoma with high grade nuclear atypia
- High prevalence of atypical hyperplasia in the endometrium of patients with epithelial ovarian cancer.
- Androgen Receptor Protein Levels Are Significantly Reduced in Serous Ovarian Carcinomas Compared with Benign or Borderline Disease but Are Not altered by Cancer Stage or Metastatic Progression
- Expression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma
- Ovarian cancer molecular pathology
- Müllerian precursor lesions in serous ovarian cancer patients: using the SEE-Fim and SEE-End protocol
- Endometrioid Endometrial Carcinoma With Atrophic Endometrium and Poor Prognosis
- The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation
- p53 Signature and Serous Tubal In-situ Carcinoma in Cases of Primary Tubal and Peritoneal Carcinomas and Serous Borderline Tumors of the Ovary
Related papers
No related papers recorded.